Evidence map›Paper›PMID 33622951›Full record

ArticleBMJ open2021

Implementation of medicines pricing policies in sub-Saharan Africa: protocol for a systematic review.

Tolib Mirzoev, Augustina Koduah, Anna Cronin de Chavez, Leonard Baatiema, Anthony Danso-Appiah, Tim Ensor, Irene Akua Agyepong, Judy M Wright, Irene A Kretchy, Natalie King

Abstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tolib MirzoevNuffield Centre for International Health and Development, University of Leeds, Leeds, West Yorkshire, UK t.mirzoev@leeds.ac.uk.ORCID 0000-0003-2959-9187
Augustina KoduahSchool of Pharmacy, University of Ghana, Legon, Greater Accra, Ghana.
Anna Cronin de ChavezNuffield Centre for International Health and Development, University of Leeds, Leeds, West Yorkshire, UK.
Leonard BaatiemaSchool of Public Health, University of Ghana, Accra-Legon, Ghana.
Anthony Danso-AppiahSchool of Public Health, University of Ghana, Accra-Legon, Ghana.
Tim EnsorNuffield Centre for International Health and Development, University of Leeds, Leeds, West Yorkshire, UK.ORCID 0000-0003-0279-9576
Irene Akua AgyepongResearch and Development Division, Ghana Health Service, Accra, Greater Accra, Ghana.
Judy M WrightLeeds Institute of Health Sciences, University of Leeds, Leeds, West Yorkshire, UK.ORCID 0000-0002-5239-0173
Irene A KretchySchool of Pharmacy, University of Ghana, Legon, Greater Accra, Ghana.
Natalie KingLeeds Institute of Health Sciences, University of Leeds, Leeds, West Yorkshire, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEnsuring universal availability and accessibility of medicines and supplies is critical for national health systems to equitably address population health needs. In sub-Saharan Africa (SSA), this is a recognised priority with multiple medicines pricing policies enacted. However, medicine prices have remained high, continue to rise and constrain their accessibility. In this systematic review, we aim to identify and analyse experiences of implementation of medicines pricing policies in SSA. Our ambition is for this evidence to contribute to improved implementation of medicines pricing policies in SSA. METHODS AND ANALYSIS: We will search: Medline, Web of Science, Scopus, Global Health, Embase, Cairn.Info International Edition, Erudit and African Index Medicus, the grey literature and reference from related publications. The searches will be limited to literature published from the year 2000 onwards that is, since the start of the Millennium Development Goals.Published peer-reviewed studies of implementation of medicines pricing policies in SSA will be eligible for inclusion. Broader policy analyses and documented experiences of implementation of other health policies will be excluded. The team will collaboratively screen titles and abstracts, then two reviewers will independently screen full texts, extract data and assess quality of the included studies. Disagreements will be resolved by discussion or a third reviewer. Data will be extracted on approaches used for policy implementation, actors involved, evidence used in decision making and key contextual influences on policy implementation. A narrative approach will be used to synthesise the data. Reporting will be informed by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols guideline. ETHICS AND DISSEMINATION: No ethics approvals are required for systematic reviews.Results will be disseminated through academic publications, policy briefs and presentations to national policymakers in Ghana and mode widely across countries in SSA. PROSPERO REGISTRATION NUMBER: CRD42020178166.

Indexed as

Delivery of Health CarePolicyCosts and Cost AnalysisGhanaHumansSystematic Reviews as Topichealth policyinternational health servicespublic health

Identifiers

PMID33622951
PMCPMC7907884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.